Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data
Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Babila Uggeri(Ospedale Maggiore di Lodi), Antonio Constán-Nava(Ospedale Maggiore di Lodi), Pietro Perotti(Provincia Autonoma di Trento), Cristina Montomoli(University of Pavia), Isabella Ruggeri, M. Della Giovanna(Azienda di Servizi alla Persona di Pavia (Italy)), Giovandomenico Violante(Ospedale Maggiore di Lodi), Elena Colombo, Maurizio Riva(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Silvestri(Ospedale Maggiore di Lodi), Mauro Agnello(Luigi Sacco Hospital), Michele Tringali(Regione Lombardia), Renato Scola(Ospedale Maggiore di Lodi)
Cited by 1
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Assessment of Normal-Appearing White and Gray Matter in Patients With Primary Progressive Multiple Sclerosis
|Archives of Neurology|2002|223